Probiotics efficacy on oxidative stress values in inflammatory bowel disease: A randomized double-blinded placebo-controlled pilot study

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 19, Issue 3, 2019, Pages 373-381

  Ballini, Andrea ^a   Santacroce, Luigi ^a,b   Cantore, Stefania ^a   Bottalico, Lucrezia ^a   Dipalma, Gianna ^a   Topi, Skender ^a,b   Saini, Rajiv ^a   Vito, Danila De ^a   Inchingolo, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Department of Civic education University AXhuvani   (Albania)

Author keywords

gut microbiota; Immune modulation; Inflammatory bowel disease (IBD); oxidative stress; Probiotics; reactive oxygen species (ROS)

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ASCORBIC ACID; BILIRUBIN; CERULOPLASMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZING AGENT; PLACEBO; PRO 15; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; TOCOPHEROL; TRANSCRIPTION FACTOR NRF2; URIC ACID;

ADULT; ANAMNESIS; ANTIOXIDANT ACTIVITY; ARTICLE; B12 DEFICIENCY; BIFIDOBACTERIUM; BODY WEIGHT LOSS; CHELATION; CHRONIC DIARRHEA; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FISTULA; INTESTINE OBSTRUCTION; LACTOBACILLUS; LEUKOCYTOSIS; LOWER ABDOMINAL PAIN; LYMPHADENOPATHY; MALABSORPTION; MALE; MIDDLE AGED; MOUTH LESION; MULTICENTER STUDY; OXIDATIVE STRESS; PALPATION; PHOTOMETRY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; STEATORRHEA; STREPTOCOCCUS; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PILOT PROJECTS; PROBIOTICS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 85065302662     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530319666181221150352     Document Type: Article

References (30)

1. Anderson, A.J.M.; Click, B.; Ramos-Rivers, C.; Babichenko, D.; Koutroubakis, I.E.; Hartman, D.J.; Hashash, J.G.; Schwartz, M.; Swoger, J.; Barrie, A.M. 3rd.; Dunn, M.A.; Regueiro, M.; Binion, D.G. Development of an inflammatory bowel disease research registry derived from observational electronic health record data for comprehensive clinical phenotyping. Dig. Dis. Sci., 2016, 61(11), 3236-3245.
2. Blumberg, R.S.; Strober, W. Prospects for research in inflammatory bowel disease. JAMA, 2001, 285(5), 643-647.
3. Shih, D.Q.; Targan, S.R.; McGovern, D. Recent advances in IBD pathogenesis: genetics and immunobiology. Curr. Gastroenterol. Rep., 2008, 10(6), 568-575.
4. Sartor, R.B. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology, 1994, 106(2), 533-539.
5. Sartor, R.B. Induction of mucosal immune responses by bacteria and bacterial components. Curr. Opin. Gastroenterol., 2001, 17(6), 555-561.
6. Satsangi, J.; Silverberg, M.S.; Vermeire, S.; Colombel, J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 2006, 55(6), 749-753.
7. Sartor, R.B. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol., 2006, 3(7), 390-407.
8. Kaser, A.; Zeissig, S.; Blumberg, R.S. Inflammatory bowel disease. Annu. Rev. Immunol., 2010, 28, 573-621.
9. Nemeth, Z.H.; Bogdanovski, D.A.; Barratt-Stopper, P.; Paglinco, S.R.; Antonioli, L.; Rolandelli, R.H. Crohn’s disease and ulcerative colitis show unique cytokine profiles. Cureus, 2017, 9(4), e1177.
10. Loh, G.; Blaut, M. Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes, 2012, 3(6), 544-555.
11. Derwa, Y.; Gracie, D.J.; Hamlin, P.J.; Ford, A.C. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2017, 46(4), 389-400.
12. Aoyagi, Y.; Park, S.; Matsubara, S.; Honda, Y.; Amamoto, R.; Kushiro, A.; Miyazaki, K.; Shephard, R.J. Habitual intake of fermented milk products containing Lactobacillus casei strain Shirota and a reduced risk of hypertension in older people. Benef. Microbes, 2017, 8(1), 23-29.
13. Amer, M.; Nadeem, M.; Nazir, S.U.R.; Fakhar, M.; Abid, F.; Ain, Q.U.; Asif, E. Probiotics and their use in inflammatory bowel disease. Altern. Ther. Health Med., 2018, 24(3), 16-23.
14. Ghouri, Y.A.; Richards, D.M.; Rahimi, E.F.; Krill, J.T.; Jelinek, K.A.; DuPont, A.W. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol., 2014, 9(7), 473-487.
15. Tatullo, M.; Marrelli, M.; Scacco, S.; Lorusso, M.; Doria, S.; Sabatini, R.; Auteri, P.; Cagiano, R.; Inchingolo, F. Relationship between oxidative stress and “burning mouth syndrome” in female patients: A scientific hypothesis. Eur. Rev. Med. Pharmacol. Sci., 2012, 16(9), 1218-1221.
16. Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K.M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campieri, M. Prophylaxis of pouchitis onset with probiotic therapy: a doubleblind, placebo-controlled trial. Gastroenterology, 2003, 124(5), 1202-1209.
17. Ballini, A.; Santacroce, L.; Cantore, S.; Bottalico, L.; Dipalma, G.; De Vito, D.; Saini, R.; Inchingolo, F. Probiotics improve urogenital health in women. Open Access Maced. J. Med. Sci., 2018, 6(10), 1845-1850.
18. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermúdez-Humarán, L.G.; Gratadoux, J.J.; Blugeon, S.; Bridonneau, C.; Furet, J.P.; Corthier, G.; Grangette, C.; Vasquez, N.; Pochart, P.; Trugnan, G.; Thomas, G.; Blottière, H.M.; Doré, J.; Marteau, P.; Seksik, P.; Langella, P. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA, 2008, 105(43), 16731-16736.
19. Kruis, W.; Fri”, P.; Pokrotnieks, J.; Lukás, M.; Fixa, B.; Kascák, M.; Kamm, M.A.; Weismueller J.; Beglinger, C.; Stolte, M.; Wolff, C.; Schulze, J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut, 2004, 53(11), 1617-1623.
20. Tatullo, M.; Gentile, S.; Paduano, F.; Santacroce, L.; Marrelli, M. Crosstalk between oral and general health status in e-smokers. Medicine (Baltimore), 2016, 95(49), e5589.
21. Marrelli, M.; Tatullo, M.; Dipalma, G.; Inchingolo, F. Oral infection by Staphylococcus aureus in patients affected by White Sponge Nevus: A description of two cases occurred in the same family. Int. J. Med. Sci., 2012, 9, 47-50.
22. Tatullo, M.; Simone, G.M.; Tarullo, F.; Irlandese, G.; Vito, D.; Marrelli, M.; Santacroce, L.; Cocco, T.; Ballini, A.; Scacco, S. Antioxidant and antitumor activity of a bioactive polyphenolic fraction isolated from the brewing process. Sci. Rep., 2016, 27(6), 36042.
23. Tatullo, M.; Marrelli, M.; Amantea, M.; Paduano, F.; Santacroce, L.; Gentile, S.; Scacco, S. Bioimpedance detection of oral lichen planus used as preneoplastic model. J. Cancer, 2015, 6(10), 976-983.
24. Marrelli, M.; Gentile, S.; Palmieri, F.; Paduano, F.; Tatullo, M. Correlation between Surgeon’s experience, surgery complexity and the alteration of stress related physiological parameters. PLoS One, 2014, 9, e112444.
25. Campanella, V.; Syed, J.; Santacroce, L.; Saini, R.; Ballini, A.; Inchingolo, F. Oral probiotics influence oral and respiratory tract infections in pediatric population: A randomized double-blinded placebo-controlled pilot study. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(22), 8034-8041.
26. Dimidi, E.; Christodoulides, S.; Scott, S.M.; Whelan, K. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv. Nutr., 2017, 8, 484-494.
27. Martínez-Martínez, M.I.; Calabuig-Tolsá, R.; Cauli, O. The effect of probiotics as a treatment for constipation in elderly people: A systematic review. Arch. Gerontol. Geriatr., 2017, 71, 142-149.
28. McFarland, L.V.; Ship, N.; Auclair, J.; Millette, M. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: Assessing the evidence. J. Hosp. Infect., 2018, 99, 443-452.
29. Goldenberg, J.Z.; Yap, C.; Lytvyn, L.; Lo, C.K.; Beardsley, J.; Mertz, D.; Johnston, B.C. Probiotics for the prevention of Clostridium difficile associated diarrhea in adults and children. Cochrane Database Syst. Rev., 2017, 12, CD006095.
30. Hajifaraji, M.; Jahanjou, F.; Abbasalizadeh, F.; Aghamohammadzadeh, N.; Abbasi, M.M.; Dolatkhah, N. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac. J. Clin. Nutr., 2018, 27, 581-591.